NICE guidance on dapagliflozin for chronic heart failure with reduced ejection fraction

被引：3
作者：
Adler, Amanda, I [1 ]
Douch, Emma
Dunning, Lorna [2 ]
Elliott, Nicole [2 ]
机构：
[1] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford OX3 7LE, England
[2] Natl Inst Hlth & Care Excellence, Level 1A,City Tower,Piccadilly Plaza, Manchester M1 4BT, Lancs, England
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2021年 / 9卷 / 05期
关键词：
D O I：
10.1016/S2213-8587(21)00072-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：261 / 263
页数：3
相关论文
共 10 条
  • [1] [Anonymous], 2012, NICE TECHN APPR GUID
  • [2] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) : 1995 - 2008
  • [3] Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
    McMurray, John J. V.
    Packer, Milton
    Desai, Akshay S.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, Victor C.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) : 993 - 1004
  • [4] National Institute for Health and Care Excellence, 2021, NICE TECHN APPR GUID
  • [5] National Institute for Health and Care Excellence, 2018, CHRONIC HEART FAILUR, DOI 10.1002/psb.1730
  • [6] National Institute for Health and Care Excellence, 2018, GUID PROC TECHN APPR
  • [7] National Institute for Health and Care Excellence (NICE), 2016, Technology appraisal guidance TA378: Remucirumab for treating advanced gastric cancer or gastro-oesophageal junction adenocarcinoma previously treated with chemotherapy
  • [8] Catalogue of EQ-5D Scores for the United Kingdom
    Sullivan, Patrick W.
    Slejko, Julia F.
    Sculpher, Mark J.
    Ghushchyan, Vahram
    [J]. MEDICAL DECISION MAKING, 2011, 31 (06) : 800 - 804
  • [9] Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study
    Taylor, Clare J.
    Ordonez-Mena, Jose M.
    Roalfe, Andrea K.
    Lay-Flurrie, Sarah
    Jones, Nicholas R.
    Marshall, Tom
    Hobbs, F. D. Richard
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 364
  • [10] Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI [10.1056/NEJMoa1812389, 10.1056/NEJMc1902837]
1